Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2008-05-06
2008-05-06
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S179000, C552S574000, C552S575000
Reexamination Certificate
active
11714724
ABSTRACT:
Compounds of the formulaand use of the compounds as medicaments.
REFERENCES:
patent: 2990401 (1961-06-01), Bernstein et al.
patent: 3183252 (1965-05-01), Crabbe
patent: 3209000 (1965-09-01), Babcock et al.
patent: 3494941 (1970-02-01), Ledig et al.
patent: 5824669 (1998-10-01), Garvey et al.
patent: 5837698 (1998-11-01), Tjoeng et al.
patent: 6197762 (2001-03-01), Garvey et al.
patent: 6579863 (2003-06-01), Garvey et al.
patent: 6610676 (2003-08-01), Del Soldato
patent: 7056905 (2006-06-01), Del Soldato
patent: 2003/0199529 (2003-10-01), Garvey et al.
patent: 1 643 034 (1971-05-01), None
patent: 2 222 491 (1972-11-01), None
patent: 1 561 908 (1969-02-01), None
patent: 2 274 309 (1976-01-01), None
patent: 1 544 512 (1979-04-01), None
patent: 94/04484 (1994-03-01), None
patent: 94/12463 (1994-06-01), None
patent: 95/09831 (1995-04-01), None
patent: 95/30641 (1995-11-01), None
patent: 97/34871 (1997-09-01), None
patent: 97/40836 (1997-11-01), None
patent: 97/41144 (1997-11-01), None
“Goodman & Gilman's The Pharmacological Basis of Therapeutics”, 9thEdition, 1996, pp. 1459-1465.
“Goodman & Gilman's The Pharmacological Basis of Therapeutics”, 9thEdition, 1996, p. 1474.
“The Merck Index”, 12thEdition, 1996.
Martindale “The Extrapharmacopeia”, 30thEdition, 1993, pp. 712-723.
“Anti-Inflammatory Potency and Gastrointestinal Toxicity of a New Compound, Nitronaproxen”, Cuzzolin et al,Pharmacological Research,vol. 31, No. 1, 1995, pp. 61-65.
“Influence of Fasting and Cimetidine on the Relationship between Ulcerogenic and Anti-Inflammatory Properties of Indomethacin”, Del Soldato et al,Br. J. Pharmac.,67, 1979, pp. 33-37.
“Feedback Inhibition of Nitric Oxide Synthase Activity by Nitric Oxide”, Assreuy et al,Br. J. Pharmacol.,108, 1993, pp. 833-837.
“Influence of Dexamethasone on the Regional Haemodynamic Responses to Lipopolysaccharide in Conscious Rats: Effects of the Non-Selective Endothelin Antagonist, SB 209670”, Gardiner et al,Br. J. Pharmacol.,117, 1996, 49P.
“Quantative in-vivo Studies on Angiogenesis in a Rat Sponge Model”, Andrade et al,Br. J. exp. Path.,68, 1987, pp. 755-766.
“Correlation of133Xe Clearance, Blood Flow and Histology in the Rat Sponge Model for Angiogenesis”, Hu et al,Laboratory Investigation,vol. 72, No. 5, 1995, pp. 601-610.
“The Effect of Glucocorticoids on Osteoblast Function”, Doherty et al,The Journal of Bone and Joint Surgery,Series A77/3, 1995, pp. 396-404.
“Synthesis and Biological Activity of Alkyl Succinates of Prednisolone”, Bayunova et al,Pharmaceutical Chemistry Journal,vol. 14, No. 12, 1981, pp. 878-880.
“1,4:3,6-Dianhydrohexitol Nitrate Derivatives. II1)Synthesis and Antianginal Activity of Aryl- or Arylcarbonylpiperazine Derivatives2)”, Hayashi et al,Chem. Pharm. Bull.,vol. 41, No. 6, Jun. 1993, pp. 1100-1110.
“Nitrate Esters of Steroid Hormones and Related Compounds, Preparation and Biological Properties”, Hodosan et al,Arzneimittel Forschung. Drug Research.,vol. 19, No. 4, 1969, pp. 684-685.
“Design of Ligands for the Glucocorticoid and Progestin Receptors”, Teutsch et al,Biochem. Soc. Trans.,vol. 19, No. 4, 1991, pp. 901-908.
“Synthesis of 5-pregnene-3β,17α-diol-20-one 3-acetate 17α-carboxylic acid esters, and studies on their structure-activity relations”,Chemical Abstracts,vol. 099, No. 11, Sep. 12, 1983, Abstract No. 088460.
“Synthesis of 3β-hydroxypregn-5en-20-one A and B ring derivatives and studies on their structure-activity relationships”,Chemical Abstracts,vol. 097, No. 11, Sep. 13, 1982, Abstract No. 092623.
“16-Hydroxylated Steroids, XXII.1The Preparation of the 16-Methyl Ether of Triamcinolone2”, Heller et al,Journal of Organic Chemistry,vol. 27, No. 1, Jan. 18, 1962, pp. 328-331.
“Antiphlogistic pregnane derivatives”,Chemical Abstracts,vol. 070, No. 15, Apr. 14, 1969, Abstract No. 068654.
Arent & Fox LLP
Badio Barbara P.
Nicox S.A.
LandOfFree
Nitrate esters of corticoid compounds and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrate esters of corticoid compounds and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrate esters of corticoid compounds and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3947098